Skip to main content
Clinical Trials/NCT07102667
NCT07102667
Enrolling By Invitation
Not Applicable

The Optimal Protein Intake to Enhance Muscle Mass in Elderly Patients With Pre-dialysis Chronic Kidney Disease: A Randomized Active-Controlled Trial

Chulalongkorn University1 site in 1 country60 target enrollmentStarted: June 1, 2025Last updated:

Overview

Phase
Not Applicable
Status
Enrolling By Invitation
Enrollment
60
Locations
1
Primary Endpoint
Between-Group Differences in Muscle Mass Changes at 6 Months

Overview

Brief Summary

The goal of this clinical trial is to determine whether increasing protein intake in elderly adults with pre-dialysis chronic kidney disease, in combination with resistance exercise, improves muscle mass without worsening renal function.The main questions it aims to answer are:

  • Does a protein intake of 1.2 g/kg BW/day combined with exercise improve muscle mass better than a protein intake of 1.0 g/kg BW/day?
  • Does a protein intake of 1.2 g/kg BW/day combined with exercise lead to greater improvements in muscle strength and function?
  • Does a protein intake of 1.2 1.2 g/kg BW/day combined with exercise cause a decline in renal function (eGFR) compared to a protein intake of 1.0 1.2 g/kg BW/day?

Researchers will compare a group assigned to intake 1.2 g/kg BW/day of protein with another group assigned to intake 1.0 g/kg BW/day, to assess whether the higher intake improves muscle mass and physical performance without causing harm.

Participants will

  • be assessed for body composition, physical performance and nutritional intake.
  • be assigned to consume protein at either 1.2 or 1.0 g/kg/day.
  • perform a home-based resistance exercise program using resistance bands.
  • provide blood and urine sample to monitor renal function.
  • visit the clinic at weeks 12 and 24 for repeated measurement.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
65 Years to — (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Thai adults aged ≥ 65 years
  • Chronic kidney disease with estimated glomerular filtration rate (eGFR) 30-59 ml/min/1.73 m2
  • Sarcopenia or presarcopenia (diagnosis based on Asian Working Group for Sarcopenia (AWGS) 2019 definition)

Exclusion Criteria

  • Active cardiopulmonary disease(s) or uncontrolled hypertension with contraindications to resistance training
  • Physically or cognitively unable to participate in the resistance exercise program (e.g. dementia), as determined by the attending physician
  • Limitations of body measurements and interpretation using Bioelectrical Impedance Analysis (BIA) e.g. presence of pacemaker, surgical metal implants
  • Meets the definition of AKI or AKD, defined as alterations in kidney function within the past 3 months
  • Severe vitamin D deficiency (25-OH Vitamin D level \< 10 ng/mL)
  • Refuses to give consent to participate in the study

Outcomes

Primary Outcomes

Between-Group Differences in Muscle Mass Changes at 6 Months

Time Frame: From enrollment to the end of intervention at 24 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Chawalya Angsuwatjarakorn, MD

Principal Investigator

Chulalongkorn University

Study Sites (1)

Loading locations...

Similar Trials